FMRP Activity and Control of Csw/SHP2 Translation Regulate MAPK-dependent Synaptic Transmission

Overview

Journal PLoS Biol

Specialty Biology

Date 2023 Jan 26

PMID 36701299

Authors

Shannon N Leahy

Chunzhu Song

Dominic J Vita

Kendal Broadie

Affiliations

Soon will be listed here.

Abstract

Noonan syndrome (NS) and NS with multiple lentigines (NSML) cognitive dysfunction are linked to SH2 domain-containing protein tyrosine phosphatase-2 (SHP2) gain-of-function (GoF) and loss-of-function (LoF), respectively. In Drosophila disease models, we find both SHP2 mutations from human patients and corkscrew (csw) homolog LoF/GoF elevate glutamatergic transmission. Cell-targeted RNAi and neurotransmitter release analyses reveal a presynaptic requirement. Consistently, all mutants exhibit reduced synaptic depression during high-frequency stimulation. Both LoF and GoF mutants also show impaired synaptic plasticity, including reduced facilitation, augmentation, and post-tetanic potentiation. NS/NSML diseases are characterized by elevated MAPK/ERK signaling, and drugs suppressing this signaling restore normal neurotransmission in mutants. Fragile X syndrome (FXS) is likewise characterized by elevated MAPK/ERK signaling. Fragile X Mental Retardation Protein (FMRP) binds csw mRNA and neuronal Csw protein is elevated in Drosophila fragile X mental retardation 1 (dfmr1) nulls. Moreover, phosphorylated ERK (pERK) is increased in dfmr1 and csw null presynaptic boutons. We find presynaptic pERK activation in response to stimulation is reduced in dfmr1 and csw nulls. Trans-heterozygous csw/+; dfmr1/+ recapitulate elevated presynaptic pERK activation and function, showing FMRP and Csw/SHP2 act within the same signaling pathway. Thus, a FMRP and SHP2 MAPK/ERK regulative mechanism controls basal and activity-dependent neurotransmission strength.

Citing Articles

Rasopathy-Associated Mutation Ptpn11 has Age-Dependent Effect on Synaptic Vesicle Recycling.

Guhathakurta D, Selzam F, Petruskova A, Weiss E, Akdas E, Montenegro-Venegas C Cell Mol Neurobiol. 2024; 44(1):77.

PMID: 39570442 PMC: 11582327. DOI: 10.1007/s10571-024-01505-1.

Muscle cofilin alters neuromuscular junction postsynaptic development to strengthen functional neurotransmission.

Christophers B, Leahy S, Soffar D, von Saucken V, Broadie K, Baylies M Development. 2024; 151(13).

PMID: 38869008 PMC: 11266751. DOI: 10.1242/dev.202558.

Experience-dependent MAPK/ERK signaling in glia regulates critical period remodeling of synaptic glomeruli.

Baumann N, Sears J, Broadie K Cell Signal. 2024; 120:111224.

PMID: 38740233 PMC: 11459659. DOI: 10.1016/j.cellsig.2024.111224.

PTPN11/Corkscrew Activates Local Presynaptic Mapk Signaling to Regulate Synapsin, Synaptic Vesicle Pools, and Neurotransmission Strength, with a Dual Requirement in Neurons and Glia.

Leahy S, Vita D, Broadie K J Neurosci. 2024; 44(17).

PMID: 38471782 PMC: 11044113. DOI: 10.1523/JNEUROSCI.1077-23.2024.

References

Linke R, Pries R, Konnecke M, Bruchhage K, Boscke R, Gebhard M . The MEK1/2-ERK1/2 pathway is activated in chronic rhinosinusitis with nasal polyps. Arch Immunol Ther Exp (Warsz). 2014; 62(3):217-29. DOI: 10.1007/s00005-014-0281-2. View

Plotnikov A, Zehorai E, Procaccia S, Seger R . The MAPK cascades: signaling components, nuclear roles and mechanisms of nuclear translocation. Biochim Biophys Acta. 2010; 1813(9):1619-33. DOI: 10.1016/j.bbamcr.2010.12.012. View

Kidd T, Bland K, Goodman C . Slit is the midline repellent for the robo receptor in Drosophila. Cell. 1999; 96(6):785-94. DOI: 10.1016/s0092-8674(00)80589-9. View

Cargnello M, Roux P . Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev. 2011; 75(1):50-83. PMC: 3063353. DOI: 10.1128/MMBR.00031-10. View

Parkinson W, Dookwah M, Dear M, Gatto C, Aoki K, Tiemeyer M . Synaptic roles for phosphomannomutase type 2 in a new Drosophila congenital disorder of glycosylation disease model. Dis Model Mech. 2016; 9(5):513-27. PMC: 4892659. DOI: 10.1242/dmm.022939. View

Darnell J, Klann E . The translation of translational control by FMRP: therapeutic targets for FXS. Nat Neurosci. 2013; 16(11):1530-6. PMC: 3999698. DOI: 10.1038/nn.3379. View

Sweatt J . Mitogen-activated protein kinases in synaptic plasticity and memory. Curr Opin Neurobiol. 2004; 14(3):311-7. DOI: 10.1016/j.conb.2004.04.001. View

Razak K, Dominick K, Erickson C . Developmental studies in fragile X syndrome. J Neurodev Disord. 2020; 12(1):13. PMC: 7196229. DOI: 10.1186/s11689-020-09310-9. View

Liu L, Mayes P, Eastman S, Shi H, Yadavilli S, Zhang T . The BRAF and MEK Inhibitors Dabrafenib and Trametinib: Effects on Immune Function and in Combination with Immunomodulatory Antibodies Targeting PD-1, PD-L1, and CTLA-4. Clin Cancer Res. 2015; 21(7):1639-51. DOI: 10.1158/1078-0432.CCR-14-2339. View

10.

Gelb B, Tartaglia M . Noonan syndrome and related disorders: dysregulated RAS-mitogen activated protein kinase signal transduction. Hum Mol Genet. 2006; 15 Spec No 2:R220-6. DOI: 10.1093/hmg/ddl197. View

11.

Stevens R, Akbergenova Y, Jorquera R, Littleton J . Abnormal synaptic vesicle biogenesis in Drosophila synaptogyrin mutants. J Neurosci. 2012; 32(50):18054-67, 18067a. PMC: 3530745. DOI: 10.1523/JNEUROSCI.2668-12.2012. View

12.

Dobrunz L, Stevens C . Heterogeneity of release probability, facilitation, and depletion at central synapses. Neuron. 1997; 18(6):995-1008. DOI: 10.1016/s0896-6273(00)80338-4. View

13.

Deng P, Sojka D, Klyachko V . Abnormal presynaptic short-term plasticity and information processing in a mouse model of fragile X syndrome. J Neurosci. 2011; 31(30):10971-82. PMC: 6623101. DOI: 10.1523/JNEUROSCI.2021-11.2011. View

14.

Caku A, Pellerin D, Bouvier P, Riou E, Corbin F . Effect of lovastatin on behavior in children and adults with fragile X syndrome: an open-label study. Am J Med Genet A. 2014; 164A(11):2834-42. DOI: 10.1002/ajmg.a.36750. View

15.

Karunanithi S, Marin L, Wong K, Atwood H . Quantal size and variation determined by vesicle size in normal and mutant Drosophila glutamatergic synapses. J Neurosci. 2002; 22(23):10267-76. PMC: 6758758. View

16.

Xue R, Ruhl D, Briguglio J, Figueroa A, Pearce R, Chapman E . Doc2-mediated superpriming supports synaptic augmentation. Proc Natl Acad Sci U S A. 2018; 115(24):E5605-E5613. PMC: 6004496. DOI: 10.1073/pnas.1802104115. View

17.

Tartaglia M, Gelb B, Zenker M . Noonan syndrome and clinically related disorders. Best Pract Res Clin Endocrinol Metab. 2011; 25(1):161-79. PMC: 3058199. DOI: 10.1016/j.beem.2010.09.002. View

18.

Dani N, Zhu H, Broadie K . Two protein N-acetylgalactosaminyl transferases regulate synaptic plasticity by activity-dependent regulation of integrin signaling. J Neurosci. 2014; 34(39):13047-65. PMC: 4172800. DOI: 10.1523/JNEUROSCI.1484-14.2014. View

19.

Johnson E, Ishak A, Naylor P, Stevenson D, Reiss A, Green T . PTPN11 Gain-of-Function Mutations Affect the Developing Human Brain, Memory, and Attention. Cereb Cortex. 2018; 29(7):2915-2923. PMC: 6611458. DOI: 10.1093/cercor/bhy158. View

20.

Vandael D, Borges-Merjane C, Zhang X, Jonas P . Short-Term Plasticity at Hippocampal Mossy Fiber Synapses Is Induced by Natural Activity Patterns and Associated with Vesicle Pool Engram Formation. Neuron. 2020; 107(3):509-521.e7. PMC: 7427323. DOI: 10.1016/j.neuron.2020.05.013. View